GMAB - Genmab AS - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMAB is currently covered by 7 analysts with an average price target of $40.77. This is a potential upside of $7.6 (22.91%) from yesterday's end of day stock price of $33.17.

Genmab AS's activity chart (see below) currently has 135 price targets and 122 ratings on display. The stock rating distribution of GMAB is 92.31% BUY and 7.69% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.77% with an average time for these price targets to be met of 70.76 days.

Highest price target for GMAB is $47, Lowest price target is $20, average price target is $35.43.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Oct-2025.

Currently out of the existing stock ratings of GMAB, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$40

$6.83 (20.59%)

$40

4 days ago
(14-Oct-2025)

9/50 (18%)

$7.28 (22.25%)

131

Buy

$43

$9.83 (29.64%)

26 days ago
(22-Sep-2025)

0/1 (0%)

$14.27 (49.67%)

Buy

$46

$12.83 (38.68%)

$45

3 months 11 days ago
(07-Jul-2025)

6/15 (40%)

$24.75 (116.47%)

87

$25

$-8.17 (-24.63%)

$31

7 months 7 days ago
(11-Mar-2025)

3/3 (100%)

$4.79 (23.70%)

316

Buy

$27

$-6.17 (-18.60%)

$31

8 months 6 days ago
(12-Feb-2025)

5/5 (100%)

$6.08 (29.06%)

179

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMAB (Genmab AS) average time for price targets to be met?

On average it took 70.76 days on average for the stock forecasts to be realized with a an average price target met ratio 31.77

Which analyst has the current highest performing score on GMAB (Genmab AS) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on GMAB (Genmab AS)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on GMAB

Which analyst is the currently most bullish on GMAB (Genmab AS)?

Kaveri Pohlman with highest potential upside - $13.83

Which analyst is the currently most reserved on GMAB (Genmab AS)?

Yaron Werber with lowest potential downside - -$13.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?